Effect of haloperidol administration on serum MHPG-SO4 levels in chronic schizophrenics.
D000328:Adult; D001711:Biotransformation; D001921:Brain / Q000378:metabolism; D002908:Chronic Disease; D006018:Glycols / Q000097:blood*; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000031:analogs & derivatives / Q000097:blood*; D008875:Middle Aged; D009638:Norepinephrine / Q000378:metabolism; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy
D006018:Glycols; C030284:3-methoxy-4-hydroxyphenylglycol sulfate; D008734:Methoxyhydroxyphenylglycol; D006220:Haloperidol; D009638:Norepinephrine